Novel On-body Evaluation of Cardiac Health for Oncology

Enrolling by invitation

Conditions studied: Cardiotoxicity, Heart Failure

In brief

The goal of this study is to develop a wearable sensor system that can estimate left ventricular ejection fraction (LVEF), which is a measurement of the heart's function.

Key facts

Study ID

NCT07158450

Run by

Skribe Medical

People needed

500

Starts

2025-10-09

Expected to finish

2026-09-01

Last updated by the study team

2026-05-20

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Undergoing an echocardiogram irrespective of participation in this study
• Willing and able to provide informed consent prior to any study-related activity

You may not qualify if…

• Have a documented allergy to potential tissue contacting system materials
• Have any condition that would cause inaccurate TTE measurements

Where it is running

• Colorado Heart and Vascular — Golden, Colorado, United States
• Clearwater Cardiovascular Consultants — Clearwater, Florida, United States
• Midwest Cardiovascular Institute — Naperville, Illinois, United States
• Cardiovascular Institute of the South — Houma, Louisiana, United States
• Strong Memorial Hospital — Rochester, New York, United States
• Cardiology Consultants of Philadelphia — Yardley, Pennsylvania, United States
• Stern Cardiovascular Center — Germantown, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.